Tracey Sacco
Corporate Officer/Principal at SCHOLAR ROCK HOLDING CORPORATION
Net worth: - $ as of 29/04/2024
Tracey Sacco active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 05/02/2023 | - |
Career history of Tracey Sacco
Former positions of Tracey Sacco
| Companies | Position | Start | End |
|---|---|---|---|
| ACCELERON PHARMA INC. | Sales & Marketing | 31/12/2011 | 31/08/2021 |
Training of Tracey Sacco
| Boston College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Stock Market
- Insiders
- Tracey Sacco
- Experience
